A092105: Randomized Phase 2 Study of Nivolumab and Ipilimumab with or without Cabozantinib in Patients with Advanced Nasopharyngeal Carcinoma That Have Progressed After Platinum Treatment and Immunotherapy
- Title
- Randomized Phase 2 Study of Nivolumab and Ipilimumab with or without Cabozantinib in Patients with Advanced Nasopharyngeal Carcinoma That Have Progressed After Platinum Treatment and Immunotherapy
- Principal Investigator
- Najeeb, Sidra
- Phase
- II
- Age Group
- Adult
- Applicable Disease Sites
- Head and Neck Cancers
- Participating Institutions
- Camden Clark Medical Center
- Mary Babb Randolph Cancer Center
- Contacts
- Nina Moore, RN
- Research Specialist
- Phone: +1 304-293-2991
- Email: nina.moore@hsc.wvu.edu
- Layla Tannoury
- Clinical Research Specialist
- Phone: +1 304-424-2585
- Email: layla.tannoury@wvumedicine.org